FIELD: chemistry.
SUBSTANCE: invention relates to a composition for use in boron-neutron capture therapy containing borylated amino acids. Borylated amino acids have the following chemical structure:
where E = CONHB12H11 and X=H. Also disclosed are kits and standard dosage forms containing said composition.
EFFECT: disclosed composition can be administered to patients as a neutron capture agent to provide a method of treating cancer, immunological disorders and other diseases using a boron-neutron capture therapy agent.
8 cl, 14 dwg, 1 tbl, 13 ex
Authors
Dates
2024-05-06—Published
2020-03-04—Filed